Rymed Tablet, Coated
Pricing Report NDC 0485-0080-01

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Rymed (NDC 0485-0080-01) is $0.22396 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 01, 2026.

As a a human over the counter drug provided by Edwards Pharmaceuticals, Inc., this medication is distributed in a 100 TABLET, COATED in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.22396
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jan 01, 2026
Billable Units
100 EA
Estimated Package Price
$22.40
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
0485-0080-01
Description
100 TABLET, COATED in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2014, the NADAC wholesale price for (NDC ) has moved within a range of $0.14542 to $0.22396 per EA. Over this 11 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1454 - $0.2240
Market Volatility
54.01% Variance
Latest Trend
4.02%
Date Unit Price Unit Source Method Rate
Jan 01, 2026 $0.22396 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jan 01, 2026 $0.22396 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Jan 01, 2026 $0.22396 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Dec 17, 2025 $0.21531 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 19, 2025 $0.21538 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 22, 2025 $0.21599 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 17, 2025 $0.20980 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 20, 2025 $0.21652 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 23, 2025 $0.21344 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 18, 2025 $0.21540 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 21, 2025 $0.21145 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 01, 2025 $0.21331 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jan 01, 2025 $0.21331 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Jan 01, 2025 $0.21331 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Dec 18, 2024 $0.20316 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 20, 2024 $0.20280 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 23, 2024 $0.20090 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 18, 2024 $0.20068 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 21, 2024 $0.20053 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 17, 2024 $0.20048 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 19, 2024 $0.20083 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 22, 2024 $0.20083 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 17, 2024 $0.20074 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 17, 2018 $0.15288 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 17, 2018 $0.15288 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 17, 2017 $0.15343 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Mar 17, 2017 $0.15343 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Jun 22, 2016 $0.14848 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 22, 2016 $0.14848 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jun 22, 2016 $0.14848 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Jan 22, 2014 $0.14542 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 22, 2014 $0.14542 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 22, 2014 $0.14542 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026